Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

English (EN)·Polski (PL)·Ukraiński (UK)
Przejdź do strony domowej biblioteki Uniwersytet Ekonomiczny we Wrocławiu Link otwiera się w nowym oknie Logo biblioteki Prolib Integro - strona głównaUniwersytet Ekonomiczny we Wrocławiu

Wyszukujesz frazę ""Le XF"" wg kryterium: Autor

  Lista filtrów
Wyrównaj
    Wyświetlanie 1-16 z 16
    Tytuł:
    Rate and Risk Factors of Superior Facet Joint Violation during Cortical Bone Trajectory Screw Placement: A Comparison of Robot-Assisted Approach with a Conventional Technique.
    Autorzy:
    Le XF; Department of Spine Surgery, Beijing Jishuitan Hospital, Beijing, China.
    Shi Z; Department of Spine Surgery, Beijing Jishuitan Hospital, Beijing, China.
    Wang QL; Department of Spine Surgery, Beijing Jishuitan Hospital, Beijing, China.
    Xu YF; Department of Spine Surgery, Beijing Jishuitan Hospital, Beijing, China.
    Zhao JW; Department of Spine Surgery, Beijing Jishuitan Hospital, Beijing, China.
    Tian W; Department of Spine Surgery, Beijing Jishuitan Hospital, Beijing, China.
    Pokaż więcej
    Źródło:
    Orthopaedic surgery [Orthop Surg] 2020 Feb; Vol. 12 (1), pp. 133-140. Date of Electronic Publication: 2019 Dec 20.
    Typ publikacji:
    Comparative Study; Journal Article
    MeSH Terms:
    Pedicle Screws*
    Cortical Bone/*surgery
    Lumbar Vertebrae/*surgery
    Robotic Surgical Procedures/*methods
    Spinal Fusion/*methods
    Zygapophyseal Joint/*injuries
    Aged ; Female ; Fluoroscopy ; Humans ; Male ; Middle Aged ; Postoperative Complications/prevention & control ; Retrospective Studies ; Risk Factors
    Czasopismo naukowe
    Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
    Tytuł:
    Comparison of Superior-Level Facet Joint Violations Between Robot-Assisted Percutaneous Pedicle Screw Placement and Conventional Open Fluoroscopic-Guided Pedicle Screw Placement.
    Autorzy:
    Zhang Q; Department of Spine Surgery, Peking University Fourth School of Clinical Medicine, Beijing, China.; Department of Spine Surgery, Beijing Jishuitan Hospital, Beijing, China.; Beijing Key Laboratory of Robotic Orthopaedics, Beijing, China.
    Xu YF; Department of Spine Surgery, Peking University Fourth School of Clinical Medicine, Beijing, China.; Department of Spine Surgery, Beijing Jishuitan Hospital, Beijing, China.; Beijing Key Laboratory of Robotic Orthopaedics, Beijing, China.
    Tian W; Department of Spine Surgery, Peking University Fourth School of Clinical Medicine, Beijing, China.; Department of Spine Surgery, Beijing Jishuitan Hospital, Beijing, China.; Beijing Key Laboratory of Robotic Orthopaedics, Beijing, China.
    Le XF; Department of Spine Surgery, Peking University Fourth School of Clinical Medicine, Beijing, China.; Department of Spine Surgery, Beijing Jishuitan Hospital, Beijing, China.; Beijing Key Laboratory of Robotic Orthopaedics, Beijing, China.
    Liu B; Department of Spine Surgery, Peking University Fourth School of Clinical Medicine, Beijing, China.; Department of Spine Surgery, Beijing Jishuitan Hospital, Beijing, China.; Beijing Key Laboratory of Robotic Orthopaedics, Beijing, China.
    Liu YJ; Department of Spine Surgery, Peking University Fourth School of Clinical Medicine, Beijing, China.; Department of Spine Surgery, Beijing Jishuitan Hospital, Beijing, China.; Beijing Key Laboratory of Robotic Orthopaedics, Beijing, China.
    He D; Department of Spine Surgery, Peking University Fourth School of Clinical Medicine, Beijing, China.; Department of Spine Surgery, Beijing Jishuitan Hospital, Beijing, China.; Beijing Key Laboratory of Robotic Orthopaedics, Beijing, China.
    Sun YQ; Department of Spine Surgery, Peking University Fourth School of Clinical Medicine, Beijing, China.; Department of Spine Surgery, Beijing Jishuitan Hospital, Beijing, China.; Beijing Key Laboratory of Robotic Orthopaedics, Beijing, China.
    Yuan Q; Department of Spine Surgery, Peking University Fourth School of Clinical Medicine, Beijing, China.; Department of Spine Surgery, Beijing Jishuitan Hospital, Beijing, China.; Beijing Key Laboratory of Robotic Orthopaedics, Beijing, China.
    Lang Z; Department of Spine Surgery, Peking University Fourth School of Clinical Medicine, Beijing, China.; Department of Spine Surgery, Beijing Jishuitan Hospital, Beijing, China.; Beijing Key Laboratory of Robotic Orthopaedics, Beijing, China.
    Han XG; Department of Spine Surgery, Peking University Fourth School of Clinical Medicine, Beijing, China.; Department of Spine Surgery, Beijing Jishuitan Hospital, Beijing, China.; Beijing Key Laboratory of Robotic Orthopaedics, Beijing, China.
    Pokaż więcej
    Źródło:
    Orthopaedic surgery [Orthop Surg] 2019 Oct; Vol. 11 (5), pp. 850-856.
    Typ publikacji:
    Comparative Study; Journal Article
    MeSH Terms:
    Pedicle Screws*
    Lumbar Vertebrae/*surgery
    Robotic Surgical Procedures/*methods
    Spinal Fusion/*methods
    Zygapophyseal Joint/*surgery
    Adult ; Aged ; Female ; Fluoroscopy ; Humans ; Male ; Middle Aged ; Prospective Studies
    Czasopismo naukowe
    Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
    Tytuł:
    Overexpression of forkhead box protein M1 (FOXM1) in ovarian cancer correlates with poor patient survival and contributes to paclitaxel resistance.
    Autorzy:
    Zhao F; Department of Pathology, The University of Hong Kong, HKSAR, China; Department of Surgery and Cancer, Imperial College London, London, United Kingdom.
    Siu MK; Obstetrics and Gynaecology, The University of Hong Kong, HKSAR, China.
    Jiang L; Department of Pathology, West China Hospital, Sichuang University, Chengdu, China.
    Tam KF; Department of Pathology, The University of Hong Kong, HKSAR, China.
    Ngan HY; Obstetrics and Gynaecology, The University of Hong Kong, HKSAR, China.
    Le XF; Department of Experimental Therapeutics, The University of Texas MD Anderson Cancer Center, Texas, United States of America.
    Wong OG; Department of Pathology, The University of Hong Kong, HKSAR, China.
    Wong ES; Department of Pathology, The University of Hong Kong, HKSAR, China.
    Gomes AR; Department of Surgery and Cancer, Imperial College London, London, United Kingdom.
    Bella L; Department of Surgery and Cancer, Imperial College London, London, United Kingdom.
    Khongkow P; Department of Surgery and Cancer, Imperial College London, London, United Kingdom.
    Lam EW; Department of Surgery and Cancer, Imperial College London, London, United Kingdom.
    Cheung AN; Department of Pathology, The University of Hong Kong, HKSAR, China; Department of Pathology, The University of Hong Kong -Shenzhen Hospital, Shenzhen, China.
    Pokaż więcej
    Źródło:
    PloS one [PLoS One] 2014 Nov 20; Vol. 9 (11), pp. e113478. Date of Electronic Publication: 2014 Nov 20 (Print Publication: 2014).
    Typ publikacji:
    Journal Article; Research Support, Non-U.S. Gov't
    MeSH Terms:
    Antineoplastic Agents, Phytogenic/*pharmacology
    Apoptosis/*drug effects
    Forkhead Transcription Factors/*metabolism
    Ovarian Neoplasms/*pathology
    Paclitaxel/*pharmacology
    Antineoplastic Agents, Phytogenic/therapeutic use ; Cell Line, Tumor ; Cell Movement ; Disease-Free Survival ; Down-Regulation/drug effects ; Drug Resistance, Neoplasm ; Female ; Follow-Up Studies ; Forkhead Box Protein M1 ; Forkhead Transcription Factors/antagonists & inhibitors ; Forkhead Transcription Factors/genetics ; G2 Phase Cell Cycle Checkpoints ; Humans ; Immunohistochemistry ; Kaplan-Meier Estimate ; Kinesins/genetics ; Neoplasm Staging ; Ovarian Neoplasms/diagnosis ; Ovarian Neoplasms/drug therapy ; Ovarian Neoplasms/mortality ; Paclitaxel/therapeutic use ; Prognosis ; Real-Time Polymerase Chain Reaction
    Czasopismo naukowe
    Pełny tekst  Link otwiera się w nowym oknieSzczegóły
    Tytuł:
    ATP directed agent, 8-chloro-adenosine, induces AMP activated protein kinase activity, leading to autophagic cell death in breast cancer cells.
    Autorzy:
    Stellrecht CM; Department of Experimental Therapeutics, University of Texas MD Anderson Cancer Center, Unit 1950, P,O, Box 301429, Houston, TX 77230-1429, USA. .
    Vangapandu HV
    Le XF
    Mao W
    Shentu S
    Pokaż więcej
    Źródło:
    Journal of hematology & oncology [J Hematol Oncol] 2014 Mar 14; Vol. 7, pp. 23. Date of Electronic Publication: 2014 Mar 14.
    Typ publikacji:
    Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
    MeSH Terms:
    2-Chloroadenosine/*analogs & derivatives
    AMP-Activated Protein Kinases/*metabolism
    Apoptosis/*drug effects
    Breast Neoplasms/*drug therapy
    2-Chloroadenosine/pharmacology ; Animals ; Autophagy/drug effects ; Breast Neoplasms/metabolism ; Breast Neoplasms/pathology ; Cell Line, Tumor ; Disease Models, Animal ; Female ; Humans ; MCF-7 Cells ; Mice ; Phosphorylation/drug effects ; Random Allocation ; Signal Transduction/drug effects ; Xenograft Model Antitumor Assays
    Czasopismo naukowe
    Pełny tekst  Link otwiera się w nowym oknieSzczegóły
    Tytuł:
    Stem cell transcription factor NANOG controls cell migration and invasion via dysregulation of E-cadherin and FoxJ1 and contributes to adverse clinical outcome in ovarian cancers.
    Autorzy:
    Siu MK; Department of Pathology, University of Hong Kong, Queen Mary Hospital, Special Administrative Region of China, Hong Kong, China. />Wong ES
    Kong DS
    Chan HY
    Jiang L
    Wong OG
    Lam EW
    Chan KK
    Ngan HY
    Le XF
    Cheung AN
    Pokaż więcej
    Źródło:
    Oncogene [Oncogene] 2013 Jul 25; Vol. 32 (30), pp. 3500-9. Date of Electronic Publication: 2012 Sep 03.
    Typ publikacji:
    Journal Article; Research Support, Non-U.S. Gov't
    MeSH Terms:
    Cadherins/*genetics
    Cell Movement/*genetics
    Forkhead Transcription Factors/*genetics
    Homeodomain Proteins/*physiology
    Ovarian Neoplasms/*pathology
    Female ; Gene Expression Regulation, Neoplastic/genetics ; Homeodomain Proteins/genetics ; Homeodomain Proteins/metabolism ; Humans ; Nanog Homeobox Protein ; Neoplasm Invasiveness ; Ovarian Neoplasms/genetics ; Prognosis ; Stem Cells/metabolism
    Czasopismo naukowe
    Pełny tekst  Link otwiera się w nowym oknieSzczegóły
    Tytuł:
    Paradoxical impact of two folate receptors, FRα and RFC, in ovarian cancer: effect on cell proliferation, invasion and clinical outcome.
    Autorzy:
    Siu MK; Department of Pathology, University of Hong Kong, Hong Kong, Special Administrative Region of China. />Kong DS
    Chan HY
    Wong ES
    Ip PP
    Jiang L
    Ngan HY
    Le XF
    Cheung AN
    Pokaż więcej
    Źródło:
    PloS one [PLoS One] 2012; Vol. 7 (11), pp. e47201. Date of Electronic Publication: 2012 Nov 07.
    Typ publikacji:
    Journal Article; Research Support, Non-U.S. Gov't
    MeSH Terms:
    Gene Expression Regulation, Neoplastic*
    Folate Receptor 1/*genetics
    Ovarian Neoplasms/*genetics
    Ovarian Neoplasms/*pathology
    Reduced Folate Carrier Protein/*genetics
    Adult ; Aged ; Aged, 80 and over ; Cadherins/genetics ; Cadherins/metabolism ; Cell Line, Tumor ; Cell Proliferation ; Disease-Free Survival ; Female ; Folate Receptor 1/metabolism ; Humans ; Middle Aged ; Neoplasm Invasiveness/genetics ; Neoplasm Invasiveness/pathology ; Ovarian Neoplasms/metabolism ; Ovarian Neoplasms/therapy ; Ovary/metabolism ; Ovary/pathology ; Promoter Regions, Genetic ; RNA, Messenger/genetics ; Reduced Folate Carrier Protein/metabolism ; Up-Regulation ; Young Adult
    Czasopismo naukowe
    Pełny tekst  Link otwiera się w nowym oknieSzczegóły
    Tytuł:
    Modulation of MicroRNA-194 and cell migration by HER2-targeting trastuzumab in breast cancer.
    Autorzy:
    Le XF; Department of Experimental Therapeutics, the University of Texas MD Anderson Cancer Center, Houston, Texas, USA. />Almeida MI
    Mao W
    Spizzo R
    Rossi S
    Nicoloso MS
    Zhang S
    Wu Y
    Calin GA
    Bast RC Jr
    Pokaż więcej
    Źródło:
    PloS one [PLoS One] 2012; Vol. 7 (7), pp. e41170. Date of Electronic Publication: 2012 Jul 19.
    Typ publikacji:
    Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
    MeSH Terms:
    Antibodies, Monoclonal, Humanized/*therapeutic use
    Breast Neoplasms/*drug therapy
    Breast Neoplasms/*metabolism
    Cell Movement/*drug effects
    MicroRNAs/*drug effects
    MicroRNAs/*metabolism
    Receptor, ErbB-2/*antagonists & inhibitors
    3' Untranslated Regions/genetics ; Animals ; Antibodies, Monoclonal, Humanized/pharmacology ; Breast Neoplasms/genetics ; Cell Line, Tumor ; Cell Movement/genetics ; Cell Proliferation/drug effects ; Female ; Flow Cytometry ; Humans ; Immunoblotting ; Mice ; Mice, Nude ; MicroRNAs/genetics ; Reverse Transcriptase Polymerase Chain Reaction ; Talin/genetics ; Talin/metabolism ; Trastuzumab
    Czasopismo naukowe
    Pełny tekst  Link otwiera się w nowym oknieSzczegóły
    Tytuł:
    Overexpression of proto-oncogene FBI-1 activates membrane type 1-matrix metalloproteinase in association with adverse outcome in ovarian cancers.
    Autorzy:
    Jiang L; Department of Pathology and, The University of Hong Kong, HKSAR, China.
    Siu MK
    Wong OG
    Tam KF
    Lam EW
    Ngan HY
    Le XF
    Wong ES
    Chan HY
    Cheung AN
    Pokaż więcej
    Źródło:
    Molecular cancer [Mol Cancer] 2010 Dec 21; Vol. 9, pp. 318. Date of Electronic Publication: 2010 Dec 21.
    Typ publikacji:
    Journal Article
    MeSH Terms:
    DNA-Binding Proteins/*metabolism
    Matrix Metalloproteinase 14/*metabolism
    Ovarian Neoplasms/*enzymology
    Ovarian Neoplasms/*pathology
    Transcription Factors/*metabolism
    Adult ; Aged ; Blotting, Western ; Cell Line ; Cell Line, Tumor ; Cell Movement/genetics ; Cell Movement/physiology ; Cell Proliferation ; Chromatin Immunoprecipitation ; DNA-Binding Proteins/genetics ; Female ; Humans ; Immunohistochemistry ; In Vitro Techniques ; Matrix Metalloproteinase 14/genetics ; Middle Aged ; Polymerase Chain Reaction ; Protein Binding ; Proto-Oncogene Mas ; Transcription Factors/genetics ; Young Adult
    Czasopismo naukowe
    Pełny tekst  Link otwiera się w nowym oknieSzczegóły
    Tytuł:
    HER2 signaling modulates the equilibrium between pro- and antiangiogenic factors via distinct pathways: implications for HER2-targeted antibody therapy.
    Autorzy:
    Wen XF; Department of Experimental Therapeutics, The University of Texas MD Anderson Cancer Center, Houston, TX 77030-4009, USA. />Yang G
    Mao W
    Thornton A
    Liu J
    Bast RC Jr
    Le XF
    Pokaż więcej
    Źródło:
    Oncogene [Oncogene] 2006 Nov 02; Vol. 25 (52), pp. 6986-96. Date of Electronic Publication: 2006 May 22.
    Typ publikacji:
    Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
    MeSH Terms:
    Antibodies, Monoclonal/*pharmacology
    Antineoplastic Agents/*pharmacology
    Mammary Neoplasms, Experimental/*metabolism
    Neovascularization, Pathologic/*metabolism
    Receptor, ErbB-2/*metabolism
    Signal Transduction/*physiology
    Animals ; Antibodies, Monoclonal, Humanized ; Blotting, Western ; Female ; Humans ; Immunohistochemistry ; Interleukin-8/metabolism ; Mammary Neoplasms, Experimental/blood supply ; Mammary Neoplasms, Experimental/drug therapy ; Mice ; Mice, Nude ; Oncogene Protein v-akt/metabolism ; Phosphatidylinositol 3-Kinases/metabolism ; Receptor, ErbB-2/antagonists & inhibitors ; Receptor, ErbB-2/immunology ; Reverse Transcriptase Polymerase Chain Reaction ; Signal Transduction/drug effects ; Thrombospondin 1/metabolism ; Transfection ; Trastuzumab ; Vascular Endothelial Growth Factor A/metabolism ; p38 Mitogen-Activated Protein Kinases/drug effects ; p38 Mitogen-Activated Protein Kinases/metabolism
    Czasopismo naukowe
    Pełny tekst  Link otwiera się w nowym oknieSzczegóły
      Wyświetlanie 1-16 z 16

      Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies